These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 11907588)

  • 1. [Implications of cAMP signaling in affective disorders].
    Pérez J; Tardito D
    Vertex; 2001; 12(43):21-6. PubMed ID: 11907588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of the cAMP signaling pathway in psychiatric disorders: a systematic review of the evidence.
    Perez J; Tardito D
    CNS Spectr; 2001 Apr; 6(4):294-305. PubMed ID: 16113628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular signaling pathways pave roads to recovery for mood disorders.
    Tanis KQ; Duman RS
    Ann Med; 2007; 39(7):531-44. PubMed ID: 17852035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia.
    Hudson CJ; Young LT; Li PP; Warsh JJ
    Synapse; 1993 Mar; 13(3):278-93. PubMed ID: 8497811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of cAMP signaling in affective disorders: implication for pathophysiology and treatment.
    Perez J; Tardito D; Mori S; Racagni G; Smeraldi E; Zanardi R
    Bipolar Disord; 2000 Mar; 2(1):27-36. PubMed ID: 11254016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current research on affective temperaments.
    Rihmer Z; Akiskal KK; Rihmer A; Akiskal HS
    Curr Opin Psychiatry; 2010 Jan; 23(1):12-8. PubMed ID: 19809321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on neuroreceptor mechanisms and their implication for the pharmacotherapy of affective disorders.
    Sulser F
    J Clin Psychiatry; 1986 Oct; 47 Suppl():13-20. PubMed ID: 3020011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders.
    Gorzalka BB; Hill MN; Hillard CJ
    Neurosci Biobehav Rev; 2008 Aug; 32(6):1152-60. PubMed ID: 18433869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in cAMP signal transduction function and gene expression related to the onset of affective disturbance--the relationship between stress, antidepressants and expression of BDNF mRNA].
    Morinobu S; Fujimaki Y; Takahashi M; Totsuka S
    Seishin Shinkeigaku Zasshi; 1996; 98(11):937-42; discussion 942-6. PubMed ID: 9102653
    [No Abstract]   [Full Text] [Related]  

  • 10. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
    Manji HK; Duman RS
    Psychopharmacol Bull; 2001; 35(2):5-49. PubMed ID: 12397885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers.
    Manji HK; Chen G
    Mol Psychiatry; 2002; 7 Suppl 1():S46-56. PubMed ID: 11986995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic AMP signaling in bivalve molluscs: an overview.
    Fabbri E; Capuzzo A
    J Exp Zool A Ecol Genet Physiol; 2010 Apr; 313(4):179-200. PubMed ID: 20127660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
    Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
    J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of surface Ig- and Lyb2-mediated B cell activation by cyclic AMP. I. Evidence for alternative regulation of signaling through two different receptors linked to phosphatidylinositol hydrolysis in murine B cells.
    Muthusamy N; Baluyut AR; Subbarao B
    J Immunol; 1991 Oct; 147(8):2483-92. PubMed ID: 1717562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A history of famous hypotheses and the future development of studies on affective disorders].
    Toru M; Itokawa M
    Nihon Rinsho; 2001 Aug; 59(8):1437-43. PubMed ID: 11519139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin receptor subtypes and affective disorders.
    Robinson DS
    Clin Neuropharmacol; 1993; 16 Suppl 3():S1-5. PubMed ID: 8131151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cholesterol levels in mood disorders and suicide.
    De Berardis D; Conti CM; Serroni N; Moschetta FS; Carano A; Salerno RM; Cavuto M; Farina B; Alessandrini M; Janiri L; Pozzi G; Di Giannantonio M
    J Biol Regul Homeost Agents; 2009; 23(3):133-40. PubMed ID: 19828089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of cAMP signals in three-dimensional microdomains using novel, real-time sensors.
    Karpen JW; Rich TC
    Proc West Pharmacol Soc; 2004; 47():1-5. PubMed ID: 15633600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localized effects of cAMP mediated by distinct routes of protein kinase A.
    Taskén K; Aandahl EM
    Physiol Rev; 2004 Jan; 84(1):137-67. PubMed ID: 14715913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysbalance of neuronal second messenger function in the aetiology of affective disorders: a pathophysiological concept hypothesising defects beyond first messenger receptors.
    Wachtel H
    J Neural Transm; 1989; 75(1):21-9. PubMed ID: 2537371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.